Image
Image
Image

Empowering Wellness with Bioflor®

Your Natural Health Solution

3P: 3 PRIVILEGES

Better Together with 3P

PAIR

Pair with any antibiotics

PROTECT

Protect your gut flora

PRESERVE

Preserve your long-term health

Image
Image

A Trusted Choice for Optimal Health

Efficacy

Backed by over 130 clinical studies and a thoroughly researched mechanism of action

Safety

Registered as a drug and trusted by more than 366 million patients across the world since 1980, present in 95 countries over the world6

Quality

Made in France through a unique manufacturing process, guaranteeing the highest quality standards

Scientific Recognition

Endorsed by renowned international scientific societies4,7

Image

NATURAL SINGLE STRAIN YEAST

Unique Strain Designation with Proven Benefits

When it comes to probiotics, the strain designation is crucial in understanding the specific benefits they offer. Some probiotic preparations contain multiple strains, making it difficult to determine which strain contributes to which health benefit1,2.

Bioflor®, with its unique strain Saccharomyces boulardii CNCM I-745, stands out as a single-strain yeast probiotic that has been extensively studied for its potential benefits in supporting gut health3. This unique strain designation is important because it allows researchers to specifically study the effects and properties of this particular strain. This ensures better control and consistency in both research and product development.

It is clinically the most studied probiotic yeast, proving its efficacy in the prevention of antibiotic-associated diarrhea4 and the treatment of acute diarrhea5. Its proven benefits make it a trusted choice for those seeking optimal digestive health.

Reference:

  1. Joly, F et al. Gut Microbiota: A full-fledged organ. 2017. Marteau, P and Dore J (Ed.). Paris: John Libbey Eurotext.
  2. Guarner et al. Probiotics and prebiotics. World Gastroenterology Organisation Global Guidelines. February 2017. https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english. Last accessed 14th November 2019.
  3. More MI, and Swidsinski, A. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis–a review. Clinical and experimental gastroenterology. 2015; 8: 237.
  4. Szajewska H, et al. Probiotics for the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications. J Pediatr Gastroenterol Nutr. 2023 Feb 1;76(2):232-247. doi: 10.1097/MPG.0000000000003633.
  5. Bioflor® (Saccharomyces boulardii). [Prescribing Information]
  6. Data on file. Biocodex.
  7. Guarner F, Sanders ME, Szajewska H, et al. World Gastroenterology Organisation Global Guideline: Probiotics and prebiotics. February 2023. Accessed 13 July, 2023.